The European Commission has announced a new funding pledge of 260 million euros to Gavi, the Vaccine Alliance, for the years 2026-2027. The funds will support Gavi's goal for 2030 to help protect 500 million children around the world, strengthen immunization systems, and boost global health security by increasing readiness to respond to disease outbreaks.

In 2020, the EU pledged Gavi 300 million euros for the period 2021-2025. The new pledge of 260 million concerns the first two years of Gavi’s next strategic cycle which coincides with the last two years of the EU’s current Multiannual Framework (MFF) 2021-2027. The Commission will remain committed to supporting Gavi in the planning of its next budget. 

Gavi, the Vaccine Alliance, works with partner countries to build up immunization systems and increase access to essential health products and healthcare services in poor countries. The EU has been providing financial and political support since 2003 and also exerts influence through Team Europe, which helps to shape Gavi’s strategic direction and policy making with its participation on the Alliance’s Board. In its next strategic cycle of 2026-2030, Gavi aims to strengthen its role in global health security, invest in emergency stockpiles, and broaden vaccine programmes to prevent outbreak-prone diseases at their source. On top of this, Gavi plans to work with regional partners to reinforce local manufacturing and build resilience. 

Keep an eye on our website for updates concerning EU funding in vaccine research and development.